Kristensen, Lars Erik <br/><br/>
Long-term work disability in patients with psoriatic arthritis treated with anti-tumour necrosis factor: a population-based regional Swedish cohort study.  [electronic resource] 

 -  Annals of the rheumatic diseases  Oct 2013 
 - 1675-9 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1468-2060 
<br/><br/><label>Standard No.: </label>10.1136/annrheumdis-2012-202229  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adalimumab<br/>Adolescent<br/>Adult<br/>Age Factors<br/>Antibodies, Monoclonal--therapeutic use<br/>Antibodies, Monoclonal, Humanized--therapeutic use<br/>Antirheumatic Agents--therapeutic use<br/>Arthritis, Psoriatic--drug therapy<br/>Cohort Studies<br/>Disability Evaluation<br/>Etanercept<br/>Female<br/>Humans<br/>Immunoglobulin G--therapeutic use<br/>Infliximab<br/>Male<br/>Middle Aged<br/>Pain Measurement--methods<br/>Pensions--statistics & numerical data<br/>Receptors, Tumor Necrosis Factor--therapeutic use<br/>Severity of Illness Index<br/>Sex Factors<br/>Sick Leave--statistics & numerical data<br/>Sweden--epidemiology<br/>Treatment Failure<br/>Tumor Necrosis Factor-alpha--antagonists & inhibitors<br/>Young Adult